| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 90.3984 | 74 |
| GSM780708 | Untreated after 4 days (C2_1) | 79.3293 | 72 |
| GSM780709 | Untreated after 4 days (C3_1) | 76.9707 | 71 |
| GSM780719 | Untreated after 4 days (C1_2) | 92.8469 | 74 |
| GSM780720 | Untreated after 4 days (C2_2) | 90.8835 | 74 |
| GSM780721 | Untreated after 4 days (C3_2) | 80.8959 | 72 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 81.3993 | 72 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 87.73 | 73 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 72.8 | 70 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 78.777 | 71 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 93.4204 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 82.2156 | 72 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 84.2006 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 92.1175 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 94.1265 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 91.9908 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 85.1623 | 73 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 79.7447 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 96.0049 | 75 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 87.2703 | 73 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 101.915 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 85.8412 | 73 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 94.1507 | 74 |